Henrique Couto Teixeira

Prof. Dr. Henrique Couto Teixeira

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Journal of Autoimmunity
Verified
Journal Article
Closed access
LALúcia C.J Abel
Lúcia C.J Abel
LRLuiz V Rizzo
Luiz V Rizzo
BIBárbara Ianni
Bárbara Ianni
FAFabiana Albuquerquea
Fabiana Albuquerquea
FBFernando Bacale
Fernando Bacale
ECEdecio Cunha-Neto
Edecio Cunha-Neto

16 March 2012 in Pharmacopsychiatry
Verified
Journal Article
Closed access
PDF file
MTM.H.F. S. Tostes
M.H.F. S. Tostes
HTHenrique Couto Teixeira
Henrique Couto Teixeira
WGW. F. Gattaz
W. F. Gattaz
MBM.A. F. Brandão
M.A. F. Brandão
NRN.R. B. Raposo
N.R. B. Raposo
Modifications in neurotrophins, neuropeptides, cytokines and nitric oxide (NO) levels in autism may represent different biological aspects of the disease. In the present study we investigate simultaneously all these variables as an attempt to clarify their interrelationships in autism. Plasma levels of vasoactive intestinal peptide (VIP), neurotrophin-3 (NT-3), cytokines and nitric oxide (NO) were determined in children with DSM-IV autistic disorder (n=24) and in age- and gender-matched healthy controls (n=24). VIP, NT-3, IFN-γ and IL-1β levels were measured by ELISA, TNF-α, IL-10, IL-6, IL-4, IL-2 were evaluated by flow cytometry, and NO by Griess reaction. Plasma levels of VIP, IFN-γ and NO were significantly higher and NT-3 plasma levels were significantly lower in children with autism, compared to the healthy subjects. In children with autism there was a positive correlation between plasma levels of NO and IFN-γ. Our results indicate the presence of altered levels of neurotrophin and neuropeptide in infantile autism and provide additional evidence that higher levels of IFN-γ may be associated with increased oxidative stress in autism.

11 July 2010 in International Immunology
Verified
Journal Article
Open access
PDF file
AMAna Márcia M. Mattos
Ana Márcia M. Mattos
CACaroline de S. Almeida
Caroline de S. Almeida
KFKees L. M. C. Franken
Kees L. M. C. Franken
Caio Cesar Souza AlvesCaio Cesar Souza Alves
Caio Cesar Souza Alves
CAClarice Abramo
Clarice Abramo
HTHenrique Couto Teixeira
Henrique Couto Teixeira
Detection of specific antibodies may represent an additional tool in diagnosis of tuberculosis (TB). Herein, levels of serum IgG antibodies against early secreted antigenic target (ESAT-6), culture filtrate antigen-10 (CFP-10) and 16kDa Mycobacterium tuberculosis antigens were measured in 33 active pulmonary TB patients (0M-TB), in 47 patients after 1–3 months of treatment (3M-TB) and in 22 patients who had completed 6 months of chemotherapy (6M-TB). The control group consisted of 38 BCG-vaccinated healthy controls (HC). In addition, IFN-γ, tumor necrosis factor (TNF)-α, IL-6, IL-2, IL-4 and IL-10 production in PBMC cultures from 20 patients were measured following stimulation with the M. tuberculosis-specific fusion protein ESAT-6/CFP-10. Elevated levels of IgG against ESAT-6, CFP-10 and 16kDa antigens were detected in 0M-TB and 3M-TB patients in comparison to the HC and 6M-TB groups. Receiver operating characteristic analysis indicated sensitivity of 85, 94 and 61% and specificity of 89, 87 and 89% for serum IgG against ESAT-6, CFP-10 and 16kDa, respectively. A predominant IgG1 response to ESAT-6 and CFP-10 was observed in 0M-TB patients, together with ESAT-6/CFP-10-specific IFN-γ, TNF-α and IL-6 that were produced at lower levels in the 6M-TB group. These data indicate that a Th1 phenotype against early phase Mtb antigens appears to be dominant in the peripheral blood of patients with active pulmonary TB that is reduced after chemotherapy. Taken together, ESAT-6/CFP-10 cytokine tests together with detecting IgG antibodies specific to ESAT-6 and CFP-10 may be the useful TB disease biomarkers in monitoring treatment success.

1 September 2008 in International Immunopharmacology
Verified
Journal Article
Closed access
MPMarcio L. De Paula
Marcio L. De Paula
DRDavid H. Rodrigues
David H. Rodrigues
HTHenrique Couto Teixeira
Henrique Couto Teixeira
MBMichele M. Barsante
Michele M. Barsante
MSMaria A. Souza
Maria A. Souza
AFAna P. Ferreira
Ana P. Ferreira

17 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PCPatrícia P Corsetti
Patrícia P Corsetti
LALeonardo Augusto de Almeida
Leonardo Augusto de Almeida
NCNatália B Carvalho
Natália B Carvalho
VAVasco Azevedo
Vasco Azevedo
TSTeane M A Silva
Teane M A Silva
Sergio Costa OliveiraSergio Costa Oliveira
Sergio Costa Oliveira
IL-10 is a cytokine that regulates the balance between pathogen clearance and immunopathology. Brucella abortus is an intracellular bacterium that causes chronic disease in humans and domestic animals. Here we evaluated the contribution of IL-10 in host immune response and pathology during B. abortus infection. To assess the role of IL-10 in vivo, IL-10 knockout (KO) or 129 Sv/Ev (wild-type) mice were infected with B. abortus and the number of viable bacteria from the spleen was determined at 1, 2, 3, 6 and 14-weeks postinfection. IL-10 KO mice showed reduced bacterial loads in the spleen when compared to wild-type mice during all time points studied. Additionally, at 14-weeks postinfection IL-10 KO mice had totally cleared the infection. This clearance was preceded by an enhanced IFN-γ, TNF-α and IL-17 responses in both the serum and the spleen of IL-10 KO mice. Additionally, dendritic cells from infected IL-10 KO mice produced elevated levels of IL-12 and TNF-α compared to wild-type animals. Histopathology analysis was performed and both KO and wild-type mice developed multifocal granulomas and necrosis in the liver. However, at six-weeks postinfection reduced numbers of granulomas was detected in IL-10 KO mice compared to wild-type animals. This reduced liver pathology at later stage of infection was accompanied by increased numbers of CD4+CD25+foxp3+ T cells and expression of TGF-β in IL-10 KO splenocytes. Taken together, our findings demonstrate that IL-10 modulates the proinflammatory immune response to B. abortus infection and the lack of IL-10 increases resistance to Brucella infection.

1 December 2002 in Infection and Immunity
Verified
Journal Article
Closed access
FCFernando L. L. Cardoso
Fernando L. L. Cardoso
PAPaulo R. Z. Antas
Paulo R. Z. Antas
AMAlexandre S. Milagres
Alexandre S. Milagres
AGAnnemieke Geluk
Annemieke Geluk
KFKees L. M. C. Franken
Kees L. M. C. Franken
ESElizabeth P. Sampaio
Elizabeth P. Sampaio
TheMycobacterium tuberculosis-specific ESAT-6 antigen induces highly potent T-cell responses and production of gamma interferon (IFN-γ), which play a critical role in protective cell-mediated immunity against tuberculosis (TB). In the present study, IFN-γ secretion by peripheral blood mononuclear cells (PBMCs) in response toM. tuberculosisESAT-6 in Brazilian TB patients was investigated in relation to clinical disease types, such as pleurisy and cavitary pulmonary TB. Leprosy patients, patients with pulmonary diseases other than TB, and healthy donors were assayed as control groups. Sixty percent of the TB patients indeed recognizedM. tuberculosisESAT-6, as did 50% of the leprosy patients and 60% of the non-TB controls. Nevertheless, the levels of IFN-γ in response to the antigen ESAT, but not to antigen 85B (Ag85B) and purified protein derivative (PPD), were significantly lower in controls than in patients with treated TB or pleural or cavitary TB. Moreover, according toMycobacterium bovisBCG vaccination status, only 59% of the vaccinated TB patients responded to ESAT in vitro, whereas 100% of them responded to PPD. Both CD4 and CD8 T cells were able to release IFN-γ in response to ESAT. The present data demonstrate the specificity of ESAT-6 ofM. tuberculosisand its ability to discriminate TB patients from controls, including leprosy patients. However, to obtain specificity, it is necessary to include quantitative IFN-γ production in response to the antigen as well, and this might limit the use of ESAT-6-based immunodiagnosis ofM. tuberculosisinfection in an area of TB endemicity.